BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8995170)

  • 1. Acute gastric outlet obstruction following the administration of prostaglandin: an additional case.
    Kobayashi N; Aida N; Nishimura G; Kashimura T; Ohta M; Kawataki M
    Pediatr Radiol; 1997 Jan; 27(1):57-9. PubMed ID: 8995170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric outlet obstruction due to an iatrogenic cause in a neonatal period - report of two cases.
    Kosiak W; Swieton D; Fryze I; Aleszewicz-Baranowska J; Duklas M; Chojnicki M
    Ultraschall Med; 2009 Aug; 30(4):401-3. PubMed ID: 17610180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiologic features of gastric outlet obstruction in infants after long-term prostaglandin administration.
    Babyn P; Peled N; Manson D; Dagan O; Silver MM; Koren G
    Pediatr Radiol; 1995; 25(1):41-3; discussion 44. PubMed ID: 7761161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Special imaging casebook. Hypoplastic left heart, prostaglandin therapy gastric focal foveolar hyperplasia and brown-fat necrosis.
    Herman TE; Siegel MJ
    J Perinatol; 2001 Jun; 21(4):263-5. PubMed ID: 11533847
    [No Abstract]   [Full Text] [Related]  

  • 5. Gastric-outlet obstruction induced by prostaglandin therapy in neonates.
    Peled N; Dagan O; Babyn P; Silver MM; Barker G; Hellmann J; Scolnik D; Koren G
    N Engl J Med; 1992 Aug; 327(8):505-10. PubMed ID: 1635565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric outlet obstruction after long-term prostaglandin administration mimicking hypertrophic pyloric stenosis.
    Lacher M; Schneider K; Dalla Pozza R; Schweinitz DV
    Eur J Pediatr Surg; 2007 Oct; 17(5):362-4. PubMed ID: 17968795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E1 and gastric outlet obstruction in infants.
    Merkus PJ; Cromme-Dijkhuis AH; Robben SG; Hess J
    Lancet; 1993 Sep; 342(8873):747. PubMed ID: 8103857
    [No Abstract]   [Full Text] [Related]  

  • 8. The development of hypertrophic pyloric stenosis in a patient with prostaglandin-induced foveolar hyperplasia.
    Callahan MJ; McCauley RG; Patel H; Hijazi ZM
    Pediatr Radiol; 1999 Oct; 29(10):748-51. PubMed ID: 10525782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric thumbprinting: diffuse gastric wall mucosal and submucosal thickening in infants with ductal-dependent cyanotic congenital heart disease maintained on long-term prostaglandin therapy.
    Joshi A; Berdon WE; Brudnicki A; LeQuesne G; Ruzal-Shapiro C; Hayes C
    Pediatr Radiol; 2002 Jun; 32(6):405-8. PubMed ID: 12029339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic focal foveolar hyperplasia in infants.
    Holland AJ; Freeman JK; Le Quesne GW; Khong TY
    Pediatr Surg Int; 1997 Sep; 12(7):497-500. PubMed ID: 9238115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications of Long-Term Prostaglandin E1 Use in Newborns With Ductal-Dependent Critical Congenital Heart Disease.
    Alhussin W; Verklan MT
    J Perinat Neonatal Nurs; 2016; 30(1):73-9. PubMed ID: 26813395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Side-effects of long-term prostaglandin E(1) treatment in neonates.
    Tálosi G; Katona M; Túri S
    Pediatr Int; 2007 Jun; 49(3):335-40. PubMed ID: 17532831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Secondary effects of prostaglandin E1 on the management of hypoplastic left heart syndrome while waiting for heart transplantation].
    Caballero S; Torre I; Arias B; Blanco D; Zabala JI; Sánchez Luna M
    An Esp Pediatr; 1998 May; 48(5):505-9. PubMed ID: 9656538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori-induced lymphonodular hyperplasia: a new cause of gastric outlet obstruction.
    Misra SP; Misra V; Dwivedi M; Singh PA
    J Gastroenterol Hepatol; 1998 Dec; 13(12):1191-4. PubMed ID: 9918424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged prostaglandin E1 therapy in a neonate with pulmonary atresia and ventricular septal defect and the development of antral foveolar hyperplasia and hypertrophic pyloric stenosis.
    Perme T; Mali S; Vidmar I; Gvardijančič D; Blumauer R; Mishaly D; Grabnar I; Nemec G; Grosek S
    Ups J Med Sci; 2013 May; 118(2):138-42. PubMed ID: 23521358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of prostaglandin-E1 treatment on pyloric wall thickness in newborns with ductal-dependent critical congenital heart diseases.
    Tandircioglu UA; Turer OB; Soyer T; Ayaz E; Ozcan HN; Yigit S; Celik HT
    Pediatr Surg Int; 2023 Mar; 39(1):144. PubMed ID: 36856877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E1-Induced Periostitis and Reversibility with Discontinuation.
    Badheka A; Bangalore Prakash P; Allareddy V
    J Pediatr; 2017 Oct; 189():237-237.e1. PubMed ID: 28709628
    [No Abstract]   [Full Text] [Related]  

  • 18. Foveolar cell hyperplasia at the pyloric canal: an unusual cause of gastric outlet obstruction in 3 young children.
    Zhao L; Jin X; Zhu J; Li X; Liang R; Guo Z
    J Pediatr Surg; 2010 Jul; 45(7):E9-12. PubMed ID: 20638512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ectopic pancreas and foveolar hyperplasia in a newborn: a unifying etiopathogenesis for gastric outlet obstruction.
    Fragoso AC; Correia-Pinto J; Carvalho JL; Dias JA; Troncoso MP; Estevão-Costa J
    J Pediatr Gastroenterol Nutr; 2004 Jul; 39(1):92-4. PubMed ID: 15187788
    [No Abstract]   [Full Text] [Related]  

  • 20. Gastric outlet obstruction: unusual ultrasonographic findings in the pyloric and antral regions.
    Hanquinet S; Damry N; Dassonville M; De Laet MH; Perlmutter N
    Pediatr Radiol; 1995 Nov; 25 Suppl 1():S163-6. PubMed ID: 8577514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.